Streetbeat News

Stock Prices

ALMS

Alumis reported a Q2 net loss of $56.5 million, which is a significant increase from the $36.3 million loss reported in the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:59 pm

DKNG

FLUT

Flutter Entertainment (NYSE:FLUT) reported strong Q2 results with earnings of $2.61 per share and revenue of $3.611 million, both up significantly year-over-year. The company raised its fiscal year U.S. revenue guidance to $6.05 billion to $6.35 billion. Shares of Flutter rose 10.18% after-hours. DraftKings (NASDAQ:DKNG) shares fell 5% after-hours following Flutter's earnings release.

Portfolio Pulse from Erica Kollmann

August 13, 2024 | 8:58 pm

QUIK

QuickLogic shares are trading lower following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:58 pm

SURG

SurgePays shares are trading lower after the company reported a year-over-year decrease in Q2 EPS results and worse-than-expected Q2 sales results.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:58 pm

SNTI

Senti Biosciences (NASDAQ:SNTI) reported a quarterly loss of $(2.45) per share for Q2, an improvement from the $(4.22) per share loss in the same period last year, representing a 41.67% increase.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:57 pm

FBIO

Fortress Biotech (NASDAQ:FBIO) reported Q2 EPS of $(0.73), beating the $(1.23) estimate, and sales of $14.90M, beating the $14.77M estimate. EPS improved by 80% YoY, while sales decreased by 14.32% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:57 pm

TCBP

TC BioPharm shares are trading lower after the company announced the pricing of a 2 million unit offering at $1 per unit.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:57 pm

IBTA

Ibotta shares are trading lower after the company reported a year-over-year decrease in Q2 adjusted EPS results and issued Q3 revenue guidance below estimates.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:56 pm

SLDB

Solid Biosciences (NASDAQ:SLDB) reported a Q2 EPS of $(0.61), beating the analyst consensus estimate of $(0.67) by 8.96%. This represents a 51.2% improvement over the $(1.25) per share loss from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:56 pm

GRAL

GRAIL shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 8:55 pm